
Defazone S 500mg/500mg Injection
Marketer
Dr. Edwin Lab
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Defazone S 500mg/500mg Injection
Cefazone-S 500mg/500mg injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, curbing infection spread. Administration must be solely under a physician's guidance. Adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt medical care. Inform your doctor of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occur. Rest, proper nutrition, and hydration are recommended for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Defazone S 500mg/500mg Injection
Managing bacterial illnesses
Major Benefits of Defazone S 500mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Defazone S 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Defazone S 500mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Defazone S 500mg/500mg Injection works:
Defazone S 500mg/500mg Injection combines Cefoperazone, an antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Cefoperazone's antibacterial efficacy.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Defazone S 500mg/500mg Injection and alcohol can lead to adverse effects including facial flushing, tachycardia, nausea, thirst, angina, and hypotension (a reaction similar to that seen with disulfiram).
PregnancySAFE IF PRESCRIBED
The injectable formulation Defazone S 500mg/500mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; despite this, data from human trials remains scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation is compatible with Defazone S 500mg/500mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Defazone S 500mg/500mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Defazone S 500mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Defazone S 500mg/500mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Defazone S 500mg/500mg Injection :
Omitting a scheduled dose of Defazone S 500mg/500mg Injection warrants immediate physician consultation.
Facts to Know About Defazone S 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
